Third-party Study Report: Investigation of Shear Stress Exerted on Proteins by Different Pump System
Exhibitor: LEVITRONIX GMBH TAIWAN BRANCH
Date: 2022-08-01
Booth No.: R1101
Shear Stress Investigations of the PuraLev® 600SU Using the Protein Shear Stress Model for Lysozyme
Keywords:
- Bioprocessing
- Pump Comparison
- 4-Piston Diaphragm Pump
- Shear Stress
- Protein Activity
Facts
In comparison to a Levitronix® pump, a 4-Piston Diaphragm Pump consists of multiple valves that restrict fluid motion to the desired direction. Valve interaction can lead to shear stress, which can result in reduced protein quality.
Test conditions
The Levitronix® PuraLev® 600SU and a 4-Piston Diaphragm Pump of corresponding hydraulic power were evaluated for their generation of shear stress and its effect on protein activity. A fixed volume of lysozyme was pumped in two identical closed-loop configurations. The flow rate of each pump was set to 10 and 20 lpm, and backpressures of 1.5, 2, 2.5 bar, respectively. Protein activity and size were measured at selected times and compared.
Results
Protein activity did not change significantly for the PuraLev® 600SU during the entire test. The fluctuations are within an acceptable margin of error. In contrast, the 4‐piston diaphragm pump showed a significant decrease in protein activity in all tests.
Protein activity and size at 10 lpm and 1.5 bar
- Reference Details: Shear Stress Investigations of the PuraLev® 600SU Using the Protein Shear Stress Model for Lysozyme - Levitronix (digtest.us)
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Mechanical Stress Exerted on Proteins by Magnetically Levitated Single-Use Centrifugal Pumps
Keywords:
- Bioprocessing
- Pump Comparison
- 4-Piston Diaphragm Pump
- Shear Stress
- Protein Activity
Facts
In comparison to a Levitronix® pump, a 4-Piston Diaphragm Pump consists of multiple valves that restrict fluid motion to the desired direction. Valve interaction can lead to shear stress, which can result in reduced protein quality.
Test conditions
The Levitronix® PuraLev® 200SU and 600SU pumps and 4-Piston Diaphragm pump of corresponding hydraulic power were compared by observing their effect evaluated for stress created and its effect on protein activity. A fixed volume of lysozyme was pumped in three identical closed-loop configurations. The flow rate of each pump was set to 10 lpm, and backpressures of 0, 0.5, and 1.5 bar, respectively. Protein activity and size were measured at selected times and compared.
Results
Protein activity did not change significantly for the PuraLev® 200SU and 600SU during the entire test. The fluctuations are within an acceptable margin of error. In contrast, the 4‐piston diaphragm pump effected a significant decrease in protein activity.
Protein activity and size at 10 lpm and 1.5 bar
-
Reference Details: Mechanical Stress Exerted on Proteins by Magnetically Levitated Single-Use Centrifugal Pumps - Levitronix (digtest.us)
For more free public details, please click on the external related links below to check the Levitronix® official website.
More Exhibitor's Press Release
- Third-party Study Report: Investigation of Shear Stress Exerted on CHO Cell by Different Pump System LEVITRONIX GMBH TAIWAN BRANCH / 2022-08-01
- Third-party Study Report: Pump Particle Shedding Evaluation LEVITRONIX GMBH TAIWAN BRANCH / 2022-08-01
- Bio Asia-Taiwan 2022 Opening! Vitae Biomedical showcases the new outstanding achievements. VITAE BIOMEDICAL CO. LTD. / 2022-07-30
- Joint Genomic Analytics Platform from Advantech, GARAOTUS and WASAI GARAOTUS (SYSTEX GROUP) / 2022-07-30
- FDA Grants the Pre-EUA Meeting Request by GoldenBiotech’s Applied Antroquinonol to Treat COVID GOLDEN BIOTECHNOLOGY CORP. / 2022-07-30
- Antroquinonol, Committed to Innovative & Breakthrough Therapy to Improve Quality of Life GOLDEN BIOTECHNOLOGY CORP. / 2022-07-30
- Italy participates for the third time in BIO ASIA with 7 companies ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2022-07-29
- AcadeMab makes its mark at 2022 BIO USA ACADEMAB BIOMEDICAL INC. / 2022-07-28
- Taiwan's AcadeMab develops groundbreaking therapy for COVID-19 Omicron variant with potent neutraliz ACADEMAB BIOMEDICAL INC. / 2022-07-28
- Home Visual Acuity tester- Don't let pseudomyopia become real myopia EYEMIKAN BIOTECH INC. / 2022-07-28
- CAMCEVI 42 mg Injection Emulsion Launched in the U.S. for the Treatment of Advanced Prostate Cancer FORESEE PHARMACEUTICALS CO., LTD. / 2022-07-27
- Foresee Announces European MAA Approval of CAMCEVI for the the Treatment of Advanced Prostate Cancer FORESEE PHARMACEUTICALS CO., LTD. / 2022-07-27
- TaiMed is your reliable biologics CDMO partner TAIMED BIOLOGICS INC. / 2022-07-27
- US FDA NDIN approval for Deglusterol, a new dietary ingredient for blood sugar control CAREGEN CO., LTD. / 2022-07-27
- 2022BioAsiaTaiwan-Golden Biotech Seminar Registration_Innovative Breakthrough_COVID-19 to Oncology GOLDEN BIOTECHNOLOGY CORP. / 2022-07-27
- Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan AMARAN BIOTECHNOLOGY, INC. / 2022-07-25
- "Montefarmaco’s portfolio covers the main segments of the self-medication market" MONTEFARMACO OTC SPA / 2022-07-22
- TMU BioMed Accelerator | 2022 Batch Demo Day (Register Now) TAIPEI MEDICAL UNIVERSITY / 2022-07-22
- BUCHI wins Swiss Export Award 2022 BUCHI TAIWAN CO., LTD. / 2022-07-21
- Automation and innovative design of BUCHI’s new Spray Dryer markedly improve spray drying performanc BUCHI TAIWAN CO., LTD. / 2022-07-21